News
RCEL
7.91
-3.60%
-0.30
Avita Medical Expands PermeaDerm Global Distribution Agreement
TipRanks · 20h ago
Weekly Report: what happened at RCEL last week (0803-0807)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 5d ago
TD Cowen Sticks to Its Buy Rating for Avita Medical (RCEL)
TipRanks · 5d ago
Avita Medical price target raised to $8 from $6 at Lake Street
TipRanks · 5d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 5d ago
This SpaceX Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Benzinga · 5d ago
At a glance: stocks gapping up premarket
Seeking Alpha · 5d ago
Avita Medical upgraded to Buy from Neutral at BTIG
TipRanks · 5d ago
Avita Medical Raised to Buy From Neutral by BTIG
Dow Jones · 5d ago
Avita Medical Price Target Announced at $7.00/Share by BTIG
Dow Jones · 5d ago
BTIG Upgrades AVITA Medical to Buy, Announces $7 Price Target
Benzinga · 5d ago
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
Barchart · 5d ago
Avita Medical Signals Record Growth And Raised Outlook
TipRanks · 5d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 5d ago
Press Release: AVITA Medical Reports Second -2-
Dow Jones · 5d ago
Lake Street Reaffirms Their Buy Rating on Avita Medical (RCEL)
TipRanks · 08/03 13:16
Weekly Report: what happened at RCEL last week (0727-0731)?
Weekly Report · 08/03 09:16
Why Celestica Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Benzinga · 07/28 09:01
Weekly Report: what happened at RCEL last week (0720-0724)?
Weekly Report · 07/27 09:17
More
Webull provides a variety of real-time RCEL stock news. You can receive the latest news about Avita Medical Inc through multiple platforms. This information may help you make smarter investment decisions.
About RCEL
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company solutions are designed to optimize wound healing, accelerate patient recovery, and improve clinical and economic outcomes across the continuum of acute wound management. Its technologies address critical healing needs arising from burns, traumatic injuries, and surgical repairs, through a portfolio and complementary products that support wound bed preparation, definitive closure, and recovery. Its portfolio includes RECELL and two complementary wound care products, PermeaDerm and Cohealyx. Its RECELL technology platform is an autologous cell harvesting technology that enables clinicians to create a suspension of a patient's own skin cells, called Spray-On Skin, at the point of care. Its PermeaDerm is a biosynthetic wound matrix that manufactures, markets, and distributes in the United States, under multi-year agreements with Stedical.